Newsroom
Hashim Ahmed presents PROMIS trial on MRI before Prostate Biopsy
A traditional transrectal biopsy is not very accurate in diagnosing significant prostate cancer
The large PROMIS trial led by Hashim Ahmed has shown that:
- a traditional transrectal biopsy is not very accurate in diagnosing significant prostate cancer
- using an MRI before biopsy can allow men to safely avoid a biopsy if the MRI is not suspicious
- MRI before biopsy can vastly improve the detection of important prostate cancer
These results are level 1b evidence which means they are robust enough to change practice across the board.
Related articles
-
Prostagram to screen for prostate cancer a step closer
British scientists develop a new scan for prostate cancer
-
Focal therapy using HIFU and cryotherapy have similar cancer control to prostatectomy
New hope of better lifestyle outcomes for prostate cancer patients
-
New hope of better lifestyle outcomes for prostate cancer patients
A new study has given real hope of better post-treatment lifestyle outcomes for men suffering with prostate cancer.